Mr Jérôme Levrat > CMS von Erlach Partners Ltd. > Geneva, Switzerland > Lawyer Profile

CMS von Erlach Partners Ltd.
Esplanade de Pont-Rouge 9
PO Box
1211 Geneva 26
Switzerland

Work Department

Private Equity & Commercial

Position

Partner

Career

Jérôme Levrat specialises in corporate law, private equity, venture capital, M&A and commercial matters.

He regularly advises funds and companies (including in the industrial, distribution, health care and life sciences, finance and energy sectors) in international and national M&A and private equity transactions, and routinely represents investors and start-ups in venture capital investments and financial rounds.

Jérôme also has solid experience in regard to commercial contracts, including joint ventures and shareholders agreements, with a particular focus on distribution contracts, and in corporate restructurings and relocations (headquarters transfers, cross-border mergers, split-ups, transformations, asset transfers, etc.).

Jérôme Levrat studied law at the Universities of Fribourg and Berlin (FUB, Germany). After graduating magna cum laude, he worked as a teaching assistant in the Department of Contract Law at the University of Fribourg. Afterwards he completed a traineeship with the Court of Justice of the canton of Geneva and then with a leading Swiss arbitration law firm. Admitted to the bar in 2008 (ranked third), he worked for five years in a prominent business law firm in Geneva before joining CMS as a Senior Associate in January 2015.

Languages

French, English, German, Bulgarian

Memberships

  • Geneva Business Law Association
  • Swiss Association of Competition Law (ASAS)

Education

  • 2008 – Bar exam
  • 2003 – Universities of Fribourg (Switzerland) and Berlin (Germany)

Lawyer Rankings

Switzerland > Commercial, corporate and M&A

Regarded as being ‘responsive, customer and solution-orientated’, CMS von Erlach Partners Ltd. draws on its global office network to operate for an array of international corporations and is routinely engaged to handle cross-border M&A and corporate transactions. The practice is headed up by four key players: Stefan Brunnschweiler, an expert across a variety of sectors that encompasses life sciences and TMT, Pascal Favre, who is a strong choice for publicly listed companies, life sciences companies, and energy and transport corporations, Daniel Jenny, who is well-versed in M&A, private equity investments, and other transactions, and Jérôme Levrat, who is fully immersed within the healthcare industry.